This report on global artificial pancreas device systems (APDS) studies the overall market scenario, the ongoing trends, future commercial prospects and the competition in the artificial pancreas device systems market. For the purpose of this study, the global artificial pancreas device systems market is studied for device type and geographical distribution. This study estimates the future prospects of the APDS, post introduction of certain target devices in the diabetes market. It is to be noted that the APDS thus described do not involve biomaterial, synthetic or artificial tissue or organs and bionic substitutes.

Based on device types, the global artificial pancreas device systems market is categorized into threshold suspended device systems, control-to-range (CTR) systems, control-to-target (CTT) systems segments. The market estimates in terms of revenue forecast for each of these segments since their product launch until the year 2023 are provided in this study, along with their respective CAGRs for the corresponding periods through 2023.

The artificial pancreas device systems market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, and Japan. Market size and forecast for these segments during 2013 to 2023 and their CAGRs for the period 2016 to 2023 are provided in this report.

Apart from the quantitative information, this report includes qualitative information sets such as drivers, challenges and opportunities, market inclination insights, major commercial events, device mechanism of artificial pancreas device systems, and benefits to the stakeholders in this market. This report also includes tools such as attractive investment proposition, Porter’s Five Forces model and market positioning of key players to assess the overall market competition. This report concludes with profiles of certain market players that have a foothold in the global diabetes management and consequently prospective pipeline in the artificial pancreas device systems market.

The major key players profiled in the artificial pancreas device systems market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The major players profiled in this report include Medtronic, Inc., Johnson & Johnson, Inc., Pancreum LLC, Tandem Diabetes Care, Inc., and JDRF.

Type of Device Segmentation Investigation

The concept of artificial pancreas has eventually evolved into a mega project over these years that involve some of the biggest names in the diabetes management device market. The mission to develop a fully automated artificial pancreas system has already moved to its later stage and the products are close to commercialization. According to World Health Organization (WHO), As of 2013, 382 Mn(or 8.3% adults) people lived with diabetes, with 46% of the pool left undiagnosed. It is anticipated that by 2035, this patient population pool will reach 592 Mn with 55% undiagnosed individuals. The burden of diabetes is gigantic, with approximately USD 548 Bn spent on diabetes treatment and management in 2013 alone. Huge support and enthusiasm for research institutions and corporations, have witnessed a transition in this field over the last decade.

In 2015, MiniMed 530G a Medtronic’s first generation artificial pancreas device was commercialized in market and resulted in a noticeable growth in the market. By The device was based on threshold suspend technology which is a proprietary technology of Medtronic, Inc. is expected to achieve an early bird advantage in the market. Hence, during the forecast period threshold suspend device system is anticipated to be the largest segment. However, in 2018 five companies are expected to enter the market with advanced technologies based on control-to-target (CTT) system with their entry market is expected to boost with a significant growth.

The geographical segmentation of the global market for artificial pancreas device systems market comprises North America, Europe, Asia-Pacific, Middle East and Africa, and Latin America. In base year 2015, North America accounted for the largest market in the artificial pancreas device systems market due to large scale research and academic studies being conducted in U.S. for further exploring the perfect design of artificial pancreas is expected to majorly drive the North America artificial pancreas device market. The major key players are based in North America which is also considered as an added advantage. Asia Pacific and Latin America is expected to project highest growth after 2023 as the cost of artificial pancreas devices and systems are predicted to be high and most of the low income countries from these regions will be difficult to penetrate with it. However, the artificial pancreas device systems market is expected to achieve maturity by 2023 which would intensify the market competition, revamp of pricing strategies, and emphasis on geographical expansion and penetration. Thus, artificial pancreas device systems market in Asia Pacific and Latin America is expected to grow at exceptional rate after 2023.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Artificial Pancreas Device Systems market are as follows:

• Research and development budgets of manufacturers and government spending
• Revenues of key companies in the market segment
• Number of end users and consumption volume, price and value.
• Geographical revenues generate by countries considered in the report
• Micro and macro environment factors that are currently influencing the Artificial Pancreas Device Systems market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of Artificial Pancreas Device Systems market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2032.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the Artificial Pancreas Device Systems market?
• Which is the largest regional market for Artificial Pancreas Device Systems market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving Artificial Pancreas Device Systems market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the Artificial Pancreas Device Systems market worldwide?